| Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities? N Poondla, AP Chandrasekaran, KS Kim, S Ramakrishna BMB reports 52 (3), 181, 2019 | 85 | 2019 |
| Dual role of deubiquitinating enzyme USP19 regulates mitotic progression and tumorigenesis by stabilizing survivin AP Chandrasekaran, A Tyagi, N Poondla, N Sarodaya, JK Karapurkar, ... Molecular Therapy 30 (11), 3414-3429, 2022 | 15 | 2022 |
| CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis N Poondla, AP Chandrasekaran, K Heese, KS Kim, S Ramakrishna Biochemical and biophysical research communications 512 (1), 60-65, 2019 | 10 | 2019 |
| Systems challenges of hepatic carcinomas: a review D Madduru, J Ijaq, S Dhar, S Sarkar, N Poondla, PS Das, S Vasquez, ... Journal of Clinical and Experimental Hepatology 9 (2), 233, 2018 | 10 | 2018 |
| Cervical cancer in the era of precision medicine: A perspective from developing countries N Poondla, D Madduru, SK Duppala, S Velpula, V Nunia, S Kharb, ... Advances in Cancer Biology-Metastasis 3, 100015, 2021 | 8 | 2021 |
| YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation AP Chandrasekaran, N Poondla, NR Ko, SJ Oh, S Ramakrishna Oncology Letters 20 (4), 1-1, 2020 | 7 | 2020 |
| Proteomic Atomics Reveals a Distinctive Uracil‐5‐Methyltransferase S Pramanik, M Thaker, AG Perumal, R Ekambaram, N Poondla, ... Molecular Informatics 39 (5), 1900135, 2020 | 3 | 2020 |
| Cover Picture: Proteomic Atomics Reveals a Distinctive Uracil‐5‐Methyltransferase (Mol. Inf. 5/2020) S Pramanik, M Thaker, AG Perumal, R Ekambaram, N Poondla, ... Molecular Informatics 39 (5), 2080501, 2020 | | 2020 |
| molecular informatics K Heese, S Pramanik, M Thaker, AG Perumal, R Ekambaram, N Poondla, ... | | |
| Advances in Cancer Biology-Metastasis N Poondla, D Madduru, SK Duppala, S Velpula, V Nunia, S Kharb, ... | | |
